Marc Geirnaert graduated from the University of Manitoba with his Bachelor of Sciences in Pharmacy in 2002. Marc is a Board Certified Oncology Pharmacist (BCOP) and received his FCAPhO (Fellow of Canadian Association of Pharmacy in Oncology) designation in 2023. Marc started working in oncology and hematology in January 2003 and has worked in a variety of clinics such as lymphoproliferative diseases, genitourinary and central nervous system tumors. Since June 2014, Marc is the Director of Provincial Oncology Drug Program at CancerCare Manitoba. Marc is also the current chair of the pan Canadian Oncology Drug Review (pCODR) Provincial Advisory Group. Marc’s interests include implementation of new therapies in oncology/hematology including immunotherapies and biosimilars.
